• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

闭合性粉刺的治疗——电灼术与外用维甲酸以及电烙术与电灼术的比较。

Treatment of closed comedones--comparisons of fulguration with topical tretinoin and electrocautery with fulguration.

作者信息

Bottomley W W, Yip J, Knaggs H, Cunliffe W J

机构信息

Leeds Foundation for Dermatological Research, Leeds General Infirmary, UK.

出版信息

Dermatology. 1993;186(4):253-7. doi: 10.1159/000247364.

DOI:10.1159/000247364
PMID:8513189
Abstract

Two consecutive studies were performed with the aim of clearly defining the optimal physical treatment for closed comedones. The first 10 patients with clinically significant numbers of facial comedones were treated with fulguration under EMLA anaesthesia on one side of the face and topical tretinoin on the opposite side. At the end of the study fulguration was shown to be significantly (p = 0.005) superior to topical tretinoin. A direct comparison of light electrocautery using EMLA anaesthetic with fulguration without anaesthesia was then performed on 12 patients. The comedones were subdivided by size into those that were approximately 1 mm or less in diameter and those of greater dimensions. In the treatment of larger comedones electrocautery was shown to be significantly superior to fulguration (p = 0.025), but there was no significant difference in the efficacy of the treatments for the smaller lesions.

摘要

为了明确界定闭合性粉刺的最佳物理治疗方法,进行了两项连续的研究。最初选取了10名面部粉刺数量具有临床意义的患者,在一侧面部使用EMLA麻醉下的电灼术进行治疗,另一侧面部使用外用维甲酸进行治疗。研究结束时发现,电灼术明显(p = 0.005)优于外用维甲酸。随后,对12名患者进行了使用EMLA麻醉的轻度电烙术与无麻醉电灼术的直接比较。粉刺按大小分为直径约1毫米或更小的粉刺和尺寸更大的粉刺。在治疗较大粉刺方面,电烙术明显优于电灼术(p = 0.025),但对于较小损害的治疗效果,两种治疗方法没有显著差异。

相似文献

1
Treatment of closed comedones--comparisons of fulguration with topical tretinoin and electrocautery with fulguration.闭合性粉刺的治疗——电灼术与外用维甲酸以及电烙术与电灼术的比较。
Dermatology. 1993;186(4):253-7. doi: 10.1159/000247364.
2
Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac) and a proprietary 0.025% tretinoin gel formulation (Aberela) in the topical control of facial acne.固定配方的1.2%磷酸克林霉素与0.025%维甲酸凝胶制剂(Velac)及一种专利的0.025%维甲酸凝胶制剂(Aberela)对面部痤疮的局部治疗效果。
J Eur Acad Dermatol Venereol. 1998 Nov;11(3):227-33.
3
Topical vitamin A acid in acne vulgaris.外用维甲酸治疗寻常痤疮。
Acta Derm Venereol Suppl (Stockh). 1975;74:133-4.
4
Topical treatment in acne: current status and future aspects.痤疮的局部治疗:现状与未来展望。
Dermatology. 2003;206(1):29-36. doi: 10.1159/000067820.
5
Comparison of two concentrations of tretinoin solution in the topical treatment of acne vulgaris.两种浓度维甲酸溶液治疗寻常痤疮的疗效比较。
Practitioner. 1976 Jan;216(1291):106-9.
6
Efficacy and tolerability of combined topical treatment of acne vulgaris with tretinoin and erythromycin in general practice.维甲酸与红霉素联合局部治疗寻常痤疮在全科医疗中的疗效和耐受性
Drugs Exp Clin Res. 1989;15(9):447-51.
7
Split-face clinical and bio-instrumental comparison of 0.1% adapalene and 0.05% tretinoin in facial acne.0.1%阿达帕林与0.05%维甲酸治疗面部痤疮的半脸临床及生物仪器比较
Dermatology. 1999;198(2):218-22. doi: 10.1159/000018117.
8
Comparative evaluation of the efficacy of four topical medications individually or in combination to treat grade I acne vulgaris.四种外用药物单独或联合使用治疗I级寻常痤疮疗效的比较评估
J Indian Med Assoc. 2009 Apr;107(4):219-22.
9
Tretinoin in acne vulgaris.维甲酸治疗寻常痤疮。
Mod Probl Paediatr. 1975;17:174-6.
10
A comparative trial of two retinoids commonly used in the treatment of acne vulgaris.两种常用于治疗寻常痤疮的维甲酸类药物的对比试验。
J Dermatolog Treat. 2001 Sep;12(3):149-57. doi: 10.1080/09546630152607880.

引用本文的文献

1
Clinical pearl: comedone extraction for persistent macrocomedones while on isotretinoin therapy.临床要点:在异维A酸治疗期间,对持续性大粉刺进行粉刺挤除术。
J Clin Aesthet Dermatol. 2011 Nov;4(11):20-1.
2
Acne vulgaris.寻常痤疮
BMJ. 1994 Mar 26;308(6932):831-3. doi: 10.1136/bmj.308.6932.831.